Cases 81 - 90 of 1,010
Astellas Pharma Inc. et al v. Ascent Pharmaceuticals, Inc.
as 1:2023cv00486
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant:
Ascent Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Newron Pharmaceuticals S.p.A et al v. MSN Laboratories Private Limited et al
as 1:2021cv00843
Defendant:
Aurobindo Pharma USA Inc., Prinston Pharmaceutical, Inc., MSN Laboratories Private Limited and others
Plaintiff:
Newron Pharmaceuticals S.p.A., MDD US Operations, LLC and Zambon S.p.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al
as 1:2023cv00548
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sebela International Limited v. Casper Pharma, LLC et al
as 1:2023cv00355
Plaintiff:
Sebela International Limited
Defendant:
Casper Pharma, LLC, Berkley Life Sciences, LLC and Gemini Insurance Company
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgment
Bayer Pharma AG et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2023cv00410
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc., Dr. Reddy's Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exela Pharma Sciences, LLC v. Hikma Pharmaceuticals USA Inc.
as 1:2023cv00137
Plaintiff:
Exela Pharma Sciences, LLC
Defendant:
Nivagen Pharmaceuticals, Inc. and Hikma Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al
as 1:2023cv00334
Plaintiff:
Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. and others
Defendant:
Biocon Pharma Limited, Biocon Limited and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan, Inc. et al v. Mankind Pharma Ltd.
as 1:2023cv00272
Plaintiff:
Allergan, Inc.
Counter Defendant:
AbbVie Inc.
Defendant:
Mankind Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bristol-Myers Squibb Company et al v. Biocon Pharma Limited
as 1:2023cv00392
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Biocon Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GMBH et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv00335
Plaintiff:
Bayer Intellectual Property GMBH, Bayer Pharma AG, Bayer AG and others
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
